Depomed

















































The home study is 9/19 with a District meeting the week later on the 26th for 3 days. Then a week in San Francisco on the 3rd of October and in the field the 10th of October. I was wondering does anyone know the salary range. I was told a great base pay but my recruiter told she could not disclose that. Well what is great to you may not be great to me so if anyone has heard anything let me know. The territories ae huge so be prepared.
 
























Not to be a downer, but Gralise is just Neurontin repackaged. It's Amrix all over again. Gabapentin has been around for decades and is used off label for everything from restless legs to neuropathy. It's 10 bucks for generic. Huge territories. Oh yeah the bonus is 25% uncapped, but it will not be on any formulary so good luck with that. Here we go again. I'm out this time. Going for interview because I was called, but I will not take this or any pharma job again.
 






Not to be a downer, but Gralise is just Neurontin repackaged. It's Amrix all over again. Gabapentin has been around for decades and is used off label for everything from restless legs to neuropathy. It's 10 bucks for generic. Huge territories. Oh yeah the bonus is 25% uncapped, but it will not be on any formulary so good luck with that. Here we go again. I'm out this time. Going for interview because I was called, but I will not take this or any pharma job again.

It could be an interesting job but their lack of focus on the impact of managed care in the current market concerns me. I also get the impression they're looking for more of the used car salesman profile rather than the professional clinician sales profile, the whole "hunter/killer/get it regardless of reality" thing. Probably a little too much individual management for me.
 






Depomed has another one ready to launch this year for hot flashes that may be added to the mix. Guess what it is?? GABAPENTIN-GR! Same drug with a new name and a new indication. This is what pharmaceuticals has been reduced to these days---just the same old stuff in a once or twice daily dose. I heard this forecasted 15 years ago at Eli Lilly and it has come to pass. The Wall Street Journal had an interesting article last week on this topic. There doesn't seem to be anything truly new on the horizon.
 






Depomed has another one ready to launch this year for hot flashes that may be added to the mix. Guess what it is?? GABAPENTIN-GR! Same drug with a new name and a new indication. This is what pharmaceuticals has been reduced to these days---just the same old stuff in a once or twice daily dose. I heard this forecasted 15 years ago at Eli Lilly and it has come to pass. The Wall Street Journal had an interesting article last week on this topic. There doesn't seem to be anything truly new on the horizon.

So, based on your comment, it is stupid to utilize cheaper, established drugs for new conditions, based on studies that show a positive effect. Lower cost to manufacture, lower cost to market, lower cost for Managed Care than completely new, novel meds where pharma companies need to recoup hundreds of millions in discovery/development expenses.

This is not the entire future of medicine, but it is a key part of controlling costs, for everyone in the chain. Get used to it.
 






So, based on your comment, it is stupid to utilize cheaper, established drugs for new conditions, based on studies that show a positive effect. Lower cost to manufacture, lower cost to market, lower cost for Managed Care than completely new, novel meds where pharma companies need to recoup hundreds of millions in discovery/development expenses.

This is not the entire future of medicine, but it is a key part of controlling costs, for everyone in the chain. Get used to it.

No, it's not stupid but it's a dead end. Think for a second, the reason many older molecules have not been used for more indications is because any potential benefit is outweighed by the significant adverse effect and compliance issues associated with short-acting multiple dose meds, delivery system can have a significant positive impact on both those issues. And, when was the last time a generic company developed anything new? Whether you like it or not it's the profits from the US sales of brand name drugs that pays for R&D any new, novel, breakthrough therapies. You want to control costs by using all generics? Fine, then research will be frozen in time at today's date without any hope of finding a cure for the common cold, or cancer maybe. Good luck with that.
 






Just tired of selling a $350 3rd tier drug against multiple $10 generics. Yes there are some tolerability and compliance benefits, but is it worth it really? On top of that, most of the products I have sold in the last 10 years have been quality-of-life drugs (Nuvigil, Ambien, Flomax, Amrix, Nexium) that go by the wayside when money gets tight. Also, to the above poster---I don't think we will ever see pharma researching cancer CURE. They are only interested in lifetime TREATMENT. If you want a really eye-opening experience, go to http://www.lef.org and read the articles and clinical trials on supplements and herbs and hormones that are not paid for by pharmaceutical companies. Life Extension is a 35 year old
non-profit foundation. Amazing.
 






Just tired of selling a $350 3rd tier drug against multiple $10 generics. Yes there are some tolerability and compliance benefits, but is it worth it really? On top of that, most of the products I have sold in the last 10 years have been quality-of-life drugs (Nuvigil, Ambien, Flomax, Amrix, Nexium) that go by the wayside when money gets tight. Also, to the above poster---I don't think we will ever see pharma researching cancer CURE. They are only interested in lifetime TREATMENT. If you want a really eye-opening experience, go to http://www.lef.org and read the articles and clinical trials on supplements and herbs and hormones that are not paid for by pharmaceutical companies. Life Extension is a 35 year old
non-profit foundation. Amazing.

Went to LEF.org, it's a typical vitamin house: Many claims of greatness, no factual data from ethical medical research to back any of it up, and lots of expensive vitamins for sale.
 






No, it's not stupid but it's a dead end. Think for a second, the reason many older molecules have not been used for more indications is because any potential benefit is outweighed by the significant adverse effect and compliance issues associated with short-acting multiple dose meds, delivery system can have a significant positive impact on both those issues. And, when was the last time a generic company developed anything new? Whether you like it or not it's the profits from the US sales of brand name drugs that pays for R&D any new, novel, breakthrough therapies. You want to control costs by using all generics? Fine, then research will be frozen in time at today's date without any hope of finding a cure for the common cold, or cancer maybe. Good luck with that.


I never said forget novel, breakthrough therapies. A basic reality is that there are dozens of drugs that have gone or will go generic soon--that are of amazing benefit to people. If Depomed or anyone else can modify the delivery of these meds to either (a) make them more efficacious, or (b) minimize the side effect profile, then more power to them. Will some offer nominal benefit? Maybe- and if they do, then the medical profession will catch up and write the generic instead. Don't pretend for a minute that improvements can't be made. Acuform is an awesome technology, and will have a seat at the table. Let's all hope that pricing is reasonable and not shoot ourselves int e foot with managed care.

good luck to all